FierceBiotechFierceBiotechResearchFierceBiotechITFierceVaccinesFiercePharmaFiercePharmaManufacturing   FierceHealthcare

Free Newsletter

About | View Sample | Privacy

Anticipating sales declines, Allergan cuts 460

Tools

Reporting a decline in earnings, Allergan announced that it would lay off 5 percent of its staff, or about 460 workers, primarily in the U.S. and Europe. Hardest hit by the cuts will be sales and marketing staff, the company said, as it adjusts to the "reduced short-term sales outlook" for some of its businesses. Release


SHARE
WITH:
Email Twitter Facebook LinkedIn StumbleUpon
Get Your FREE FiercePharma Email Newsletter:
Be the first to comment
More stories about Allergan   restructuring   pharmaceutical layoffs  

Comments

Post new comment

The content of this field is kept private and will not be shown publicly.

More information about formatting options

To combat spam, please enter the code in the image.